Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease.
about
Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons DiseaseWhat is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?Tool compounds robustly increase turnover of an artificial substrate by glucocerebrosidase in human brain lysatesDifferential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluidCerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directionsAre there roles for brain cell senescence in aging and neurodegenerative disorders?Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseSelective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.The Interplay between Alpha-Synuclein Clearance and SpreadingCathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment.Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.Alpha galactosidase A activity in Parkinson's disease.Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients.Ageing, Cellular Senescence and Neurodegenerative Disease
P2860
Q26776209-CA597B85-00A6-43A6-9F8C-A101BF1B8F96Q28083203-AEFBC97D-24E0-407C-A6AE-F2ED8B860A88Q28543988-6770B927-DE4E-4D1A-8A65-02AAB6F72133Q33768132-79893091-418D-4D6D-B1D0-0DF2BC59BEADQ33831118-EEF74E0A-5700-408E-A563-84CE2C5ED1CBQ34237637-3BAEDA09-21D2-44C2-AC9B-B276F328BAD1Q34688159-4F4A4CEB-DE99-4EA7-B126-8F20292A52DCQ34714560-089F5956-051E-4D2D-A784-B2AC386474ADQ34806122-620A13EE-A080-4D38-B946-C3EF1C2F5ECEQ35596071-E1512070-AE14-40E2-B5B2-AF7759EFF16DQ35833984-1F2BC495-EAF3-4EDA-9ABB-88BD2EA137EBQ37672390-40A414DE-1547-45C4-8C67-411E67EED73AQ38271572-30274DBB-C593-4CBB-9E3B-234045519469Q38765856-0E5930DC-2BDC-4338-A934-18F7071CB20EQ38811401-8304980C-4970-40E7-BB61-8C71A8489259Q38825497-6FF8A959-49B4-4D23-BFF6-1D20C03BF647Q41666702-362335F7-9B4E-4426-A765-3A74EC89DBA0Q47840041-7199CE72-6BC0-42B9-9BB7-E33F0870ABC2Q48184416-55631036-B1B6-4286-A8EB-EF7890E6C5A8Q55357756-2C860D46-D6BA-4E80-BFC2-8427DFCBC090Q59133878-F2683A1E-4697-4489-BF6E-3C226B6A85A3
P2860
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Changes in endolysosomal enzym ...... ents with Parkinson's disease.
@en
Changes in endolysosomal enzym ...... ents with Parkinson's disease.
@nl
type
label
Changes in endolysosomal enzym ...... ents with Parkinson's disease.
@en
Changes in endolysosomal enzym ...... ents with Parkinson's disease.
@nl
prefLabel
Changes in endolysosomal enzym ...... ents with Parkinson's disease.
@en
Changes in endolysosomal enzym ...... ents with Parkinson's disease.
@nl
P2093
P2860
P356
P1433
P1476
Changes in endolysosomal enzym ...... ents with Parkinson's disease.
@en
P2093
Davide Chiasserini
Emanuele Persichetti
Karin D van Dijk
Lucilla Parnetti
Paolo Calabresi
Paolo Eusebi
Tommaso Beccari
Wilma D J van de Berg
P2860
P304
P356
10.1002/MDS.25495
P407
P577
2013-05-27T00:00:00Z